a public good project by the
Synthesis
Company
of California

© 2026

M Mousseau | doi.page

0 works0 citations0 h-index

M Mousseau

Publications by Year

Research Areas

Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, BRCA gene mutations in cancer, Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies

Most-Cited Works

→ Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy.(1997)429 cited
→ A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)(2016)278 cited
→ Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy.(1996)160 cited
→ A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma(2003)152 cited
→ Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601(2012)104 cited
→ A Model for the Measurement of Patient Activity in a Hospital Suite

(2006)

94 cited

→ Multicentric evaluation of the MDR phenotype in leukemia(1997)85 cited

→ First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial)(1999)62 cited

→ A study of the expression of four chemoresistance-related genes in human primary and metastatic brain tumours(1993)45 cited

→ Efficacy and safety of the paclitaxel and carboplatin combination in patients with previously treated advanced ovarian carcinoma(1998)43 cited